Expectations About the COVID-19 Vaccines
NCT04928911 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1176
Last updated 2024-01-18
Summary
This study collects information on expectations and attitudes towards the COVID-19 vaccines in participants about to receive a COVID-19 vaccine. This information will be linked to data on side effect occurrence collected in an independent study.
Conditions
- Vaccine Adverse Reaction
Interventions
- BIOLOGICAL
-
Adults about to receive a COVID-19 vaccine fill out a questionnaire of potential predictors of side effect occurrence
Sponsors & Collaborators
-
University of Aarhus
lead OTHER
Principal Investigators
-
Lene Vase · University of Aarhus
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-06-11
- Primary Completion
- 2023-03-31
- Completion
- 2023-03-31
Countries
- Denmark
Study Locations
More Related Trials
-
COVID-19 Vaccine Effectiveness Among Health Workers in Georgia
NCT04868448 ·Status: UNKNOWN
-
Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods
NCT04703790 ·Status: COMPLETED
-
An Immunity Persistence Study of Live Attenuated Varicella Vaccine
NCT05095701 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine
NCT02983656 ·Status: COMPLETED
-
National Vaccine Adverse Event Reporting Survey and Etiology
NCT05095844 ·Status: UNKNOWN
-
To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults
NCT04885361 ·Status: UNKNOWN ·Phase: PHASE1
-
Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)
NCT05128721 ·Status: UNKNOWN ·Phase: PHASE1
-
COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities
NCT04860258 ·Status: TERMINATED ·Phase: PHASE3
-
Covid-19 Vaccine Cohort in Specific Populations
NCT04824651 ·Status: UNKNOWN
-
Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine
NCT02026089 ·Status: WITHDRAWN ·Phase: PHASE4
-
Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus
NCT05460429 ·Status: UNKNOWN ·Phase: PHASE4
-
Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination
NCT04941144 ·Status: COMPLETED
-
Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults
NCT04546841 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers
NCT04666012 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Adolescents Seeking COVID Vaccination (Teen COVID Vax)
NCT05537103 ·Status: COMPLETED
-
Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers
NCT05047692 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-ST Against COVID-19
NCT04895449 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of Patterns of Immune Response to COVID 19 Vaccination
NCT05408299 ·Status: UNKNOWN
-
Comparative Evaluation of Covid-19 Vaccines Response
NCT04895007 ·Status: UNKNOWN
-
A Trial Evaluating the Safety and Immunogenicity of 3 COVID-19 SARS-CoV-2 RNA Vaccines in Healthy Adults
NCT05037097 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
NCT07300839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization
NCT05150392 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults
NCT04591184 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Effectiveness of Moderna COVID-19 Vaccine
NCT05933304 ·Status: COMPLETED
-
VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIA
NCT05135455 ·Status: COMPLETED